(Q46681454)

24 December 2017

title

Aldosterone and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells (English)

1 reference

24 December 2017

author name string

Wei Huang

1

1 reference

24 December 2017

Chen Xu

2

1 reference

24 December 2017

Kyoung W Kahng

3

1 reference

24 December 2017

Nancy A Noble

4

1 reference

24 December 2017

Wayne A Border

5

1 reference

24 December 2017

Yufeng Huang

6

1 reference

24 December 2017

publication date

26 March 2008

1 reference

24 December 2017

American Journal of Physiology - Renal Physiology

published in

1 reference

24 December 2017

volume

294

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

F1287-95

1 reference

24 December 2017

Regression of existing glomerulosclerosis by inhibition of aldosterone

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

ACE inhibitor-angiotensin receptor blocker combinations: a clinician's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Plasminogen activator inhibitor-1 and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

PAI-1 as a target in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Effect of aldosterone on renal transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Aldosterone promotes fibronectin production through a Smad2-dependent TGF-beta1 pathway in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Transforming Growth Factor-β-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in β6−/− Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Beneficial impact of spironolactone in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

TGF-beta isoforms in renal fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00017.2008

10.1152/AJPRENAL.00017.2008

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017